STEMCELL Technologies
![](https://i0.wp.com/3rc.org/wp-content/uploads/2024/04/Stemcell-logo.jpg?fit=592%2C254&ssl=1)
We are the world-leading provider of reagents and services for generating organoid and stem cell-derived models of healthy and diseased human tissues.
AnaBios
![](https://i0.wp.com/3rc.org/wp-content/uploads/2024/03/ANABIOS-LOGO-F.jpg?fit=450%2C195&ssl=1)
AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.
Hesperos Inc.
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/HesperosS2-1.png?fit=800%2C336&ssl=1)
Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.
CN Bio
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/CN-BioS2.png?fit=800%2C336&ssl=1)
CN Bio is a leading bioengineering company specializing in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.
MIMETAS
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/MimetasS2.png?fit=800%2C336&ssl=1)
Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.